Expression of Toll-Like Receptors in peripheral blood mononuclear cells and response to cognitive-behavioral therapy in major depressive disorder

In recent years, increased attention has been paid to the inflammatory mechanisms of major depressive disorder (MDD). The aim of the present study was to investigate pro-inflammatory pathways related to the "leaky gut" hypothesis of MDD, which is based on the putative intestinal translocat...

Teljes leírás

Elmentve itt :
Bibliográfiai részletek
Szerzők: Kéri Szabolcs
Szabó Csilla
Kelemen Oguz
Dokumentumtípus: Cikk
Megjelent: 2014
Sorozat:BRAIN BEHAVIOR AND IMMUNITY 40
doi:10.1016/j.bbi.2014.03.020

mtmt:2782621
Online Access:http://publicatio.bibl.u-szeged.hu/11361
LEADER 02923nab a2200229 i 4500
001 publ11361
005 20200221114354.0
008 170522s2014 hu o 0|| zxx d
022 |a 0889-1591 
024 7 |a 10.1016/j.bbi.2014.03.020  |2 doi 
024 7 |a 2782621  |2 mtmt 
040 |a SZTE Publicatio Repozitórium  |b hun 
041 |a zxx 
100 1 |a Kéri Szabolcs 
245 1 0 |a Expression of Toll-Like Receptors in peripheral blood mononuclear cells and response to cognitive-behavioral therapy in major depressive disorder  |h [elektronikus dokumentum] /  |c  Kéri Szabolcs 
260 |c 2014 
300 |a 235-243 
490 0 |a BRAIN BEHAVIOR AND IMMUNITY  |v 40 
520 3 |a In recent years, increased attention has been paid to the inflammatory mechanisms of major depressive disorder (MDD). The aim of the present study was to investigate pro-inflammatory pathways related to the "leaky gut" hypothesis of MDD, which is based on the putative intestinal translocation of Gram-negative bacteria and a subsequent abnormal immune response mediated by the Toll-Like Receptor-4 (TLR-4) pathway. 50 patients with first-episode MDD and 30 healthy control subjects participated in the study. Real-time quantitative PCR was used to measure TLR-4 and TLR-2 RNA from peripheral mononuclear blood cells, as well as the expression of NF-kappabeta, a key transcription factor of the pro-inflammatory response. TLR-4 protein expression was determined by using flow cytometry. TLR-2 served as a control molecule. Low-grade inflammation was characterized by the measurement of interleukin-6 (IL-6) and C-reactive protein (CRP). Bacterial translocation was investigated by the measurement of the 16S rRNA subunit (16S rDNA) of intestinal microbiota in the blood plasma of the participants. We performed these analyses before (t1) and after (t2) cognitive-behavioral therapy (CBT) in MDD. The healthy control subjects were also assessed two times. We found significantly elevated expressions of all three markers (TLR-4 RNA and protein, NF-kappabeta RNA) and 16S rDNA in MDD at t1 relative to healthy control subjects. These markers showed a significant decrease during CBT (t1>t2 in MDD). We observed no between-group differences and changes in the case of TLR-2. Greater reduction of pro-inflammatory markers during CBT was associated with more pronounced clinical improvement. IL-6 and CRP displayed a moderately elevated level in MDD and did not change during CBT. In conclusion, TLR-4 signaling is up-regulated in newly diagnosed patients with MDD, which may be related to bacterial translocation or to the presence of various damage-associated molecular patterns. Clinical improvement during psychotherapy is associated with decreased expression of pro-inflammatory markers. 
700 0 1 |a Szabó Csilla  |e aut 
700 0 1 |a Kelemen Oguz  |e aut 
856 4 0 |u http://publicatio.bibl.u-szeged.hu/11361/1/Keri_BrainBehavImmun_2014.pdf  |z Dokumentum-elérés